LUNG PEER ANALYSIS

Pulmonx Corp — metric-by-metric comparison with peers and the industry median

LUNGPulmonx Corp

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

LUNGIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	LUNG	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
P/E	—	—	597.66	121.43	20.83●	—	27.09
P/B	1.40	1.31	1.08	13.25	2.51	-77.13●	2.51
EV/EBITDA	—	34.63	10.94	25.26	9.98●	—	15.39
P/S	0.72●	2.93	1.18	7.60	2.11	252.89	2.62

Financial Health
Metric	LUNG	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
Current Ratio	4.91	2.31	3.58	2.25	2.57	6.57●	3.28
Debt/Equity	123.0%	28.1%	1.0%	35.0%	62.9%	-22.6%●	44.7%
NetDebt/EBITDA	0.11	4.71	-1.64●	0.42	1.72	0.71	0.82

Profitability
Metric	LUNG	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
Net Margin	-60.1%	-45.0%	0.2%	6.3%	10.1%●	-3,684.6%	-5.7%
ROE	-86.2%	-21.0%	0.2%	12.9%●	12.1%	—	-8.6%
ROA	-39.3%	-15.7%	0.2%	8.0%●	6.1%	-264.3%	-6.4%
EBITDA Margin	-54.5%	9.8%	9.4%	30.6%●	25.6%	-818.8%	5.2%

Growth + Dividend
Metric	LUNG	ANGEN	MEDTR	ONCSM	SN	4DX	Ind. Median
Rev. Growth	1.2%	11.7%	6.5%	39.1%●	—	-26.0%	7.4%
NI Growth	—	—	-62.9%	—	—	—	16.7%
Div. Yield	—	0.0%	1.1%	0.0%	3.5%●	—	1.1%
Payout	—	0.0%	656.3%	0.0%	52.8%	—	39.0%

Valuation
Metric	LUNG	TELA	OM	NNOX	ARAY	MXCT	Ind. Median
P/E	—	—	—	—	—	—	27.09
P/B	1.40	-9.84●	0.79	0.66	0.74	0.82	2.51
EV/EBITDA	—	—	—	—	—	—	15.39
P/S	0.72	0.63	0.75	5.73	0.07●	4.27	2.62

Financial Health
Metric	LUNG	TELA	OM	NNOX	ARAY	MXCT	Ind. Median
Current Ratio	4.91	3.61	6.29	3.64	1.42	12.04●	3.28
Debt/Equity	123.0%	-1,084.3%●	91.0%	6.0%	437.3%	10.4%	44.7%
NetDebt/EBITDA	0.11	-0.52	0.96	0.74	-22.14●	-0.08	0.82

Profitability
Metric	LUNG	TELA	OM	NNOX	ARAY	MXCT	Ind. Median
Net Margin	-60.1%	-49.3%	-63.7%	-523.8%	-10.8%●	-121.2%	-5.7%
ROE	-86.2%	—	-53.2%	-50.1%	-101.1%	-21.3%●	-8.6%
ROA	-39.3%	-54.2%	-27.2%	-44.4%	-9.9%●	-18.4%	-6.4%
EBITDA Margin	-54.5%	-40.2%	-48.6%	-336.6%	-1.5%●	-107.3%	5.2%

Growth + Dividend
Metric	LUNG	TELA	OM	NNOX	ARAY	MXCT	Ind. Median
Rev. Growth	1.2%	13.5%	2.0%	25.7%●	-7.9%	-14.3%	7.4%
NI Growth	—	—	—	—	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on LUNG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.